Ajith P. Nair, MD

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Advanced Heart Failure and Transplant Cardiology Fellowship


  • Congestive Heart Failure
  • Cardiac Transplantation
  • Mechanical Assist Devices
  • Pulmonary Hypertension
  • General Cardiology


  • Undergraduate:

    University of Texas at Austin

  • Medical School:

    University of Texas Southwestern

  • Internship:

    Mount Sinai Hospital

  • Residency:

    Mount Sinai Hospital

  • Fellowships:

    Mount Sinai Hospital

Academic & Clinical Affiliations


  • Internal Medicine, American Board of Internal Medicine
  • Cardiovascular Diseases, American Board of Internal Medicine
  • Advanced Heart Failure and Transplant, Cardiology American Board of Internal Medicine

Honors, Awards and Memberships


Patel, R. B., Reddy, V. Y., Komtebedde, J. et al. (2023). Atrial fibrillation burden and atrial shunt therapy in heart failure with preserved ejection fraction. JACC Heart Fail, S2213-1779(23)00298–6. https://doi.org/10.1016/j.jchf.2023.05.024.
Hoeper, M. M., Badesch, D. B., Ghofrani, H. A. et al. (2023). Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med 388, 1478–1490. https://doi.org/10.1056/NEJMoa2213558.
Civitello, A. and Nair, A. (2023). Simultaneous heart-kidney transplantation: balancing competing outcomes for transplant wait-listed patients. J Am Coll Cardiol 81, 741–742. https://doi.org/10.1016/j.jacc.2022.12.010.
Nair, A. and Lamba, H. (2023). Left ventricular assist devices and renal ramifications. J Am Heart Assoc 12, e028450. https://doi.org/10.1161/JAHA.122.028450.
Nair, A., Xie, L. and Silva Enciso, J. E. (2023). Myosin inhibitors: the next generation. J Am Coll Cardiol 81, 46–48. https://doi.org/10.1016/j.jacc.2022.10.018.
Inchaustegui, C. A., Patel, A., Lamba, H. K. et al. (2022). Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. https://doi.org/10.1007/s10047-022-01367-8.
Najjar, S. N., Dweck, B. E., Nair, A. et al. (2022). Relation of T wave positivity in lead aVR to ischemic etiology of cardiomyopathy. Am J Cardiol, S0002-9149(22)00701–9. https://doi.org/10.1016/j.amjcard.2022.06.043.
Nair, A. and Deswal, A. (2022). COVID-19-associated fulminant myocarditis: Pathophysiology-related phenotypic variance. J Am Coll Cardiol 80, 313–315. https://doi.org/10.1016/j.jacc.2022.06.003.
Al Rifai, M., Newby, L. K., Nair, A. P. et al. (2022). SGLT-2 inhibitors for patients with heart failure: what have we learned recently? Curr Atheroscler Rep. https://doi.org/10.1007/s11883-022-01038-2.
Borlaug, B. A., Blair, J., Bergmann, M. W. et al. (2022). Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation 145, 1592–1604. https://doi.org/10.1161/CIRCULATIONAHA.122.059486.